Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRC
1376
Commerce.com Inc Series 1
CMRC
$272M
| $18.7M | 0.01% |
+368,375
| New | +$22.5M |
|
1377
Ares Capital
ARCC
$13.4B
| $18.6M | 0.01% |
914,605
+895,453
| +4,676% | +$17.9M |
|
1378
Cincinnati Financial
CINF
$27.8B
| $18.6M | 0.01% |
162,766
+149,219
| +1,101% | +$17.7M |
|
1379
Maravai LifeSciences
MRVI
$972M
| $18.6M | 0.01% |
378,750
+100
| +0% | +$4.88K |
|
|
BTWN
1380
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
| $18.6M | 0.01% |
1,891,910
| – | – |
|
1381
Brinker International
EAT
$8.82B
| $18.6M | 0.01% |
378,373
+67,474
| +22% | +$3.67M |
|
1382
Motorola Solutions
MSI
$72.1B
| $18.5M | 0.01% |
79,667
-142,775
| -64% | -$33.1M |
|
|
LCA
1383
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
| $18.5M | 0.01% |
1,899,978
+1,695,911
| +831% | +$16.5M |
|
1384
Kornit Digital
KRNT
$677M
| $18.5M | 0.01% |
127,830
+39,660
| +45% | +$5.23M |
|
|
DAY
1385
DELISTED
Dayforce
DAY
| $18.4M | 0.01% |
163,464
+136,571
| +508% | +$14.3M |
|
1386
CALL
Intuitive Surgical
ISRG
$127B
| $18.4M | 0.01% |
55,500
-600
| -1% | -$201K |
|
1387
PUT
Expedia Group
EXPE
$36.5B
| $18.4M | 0.01% |
112,100
| – | – |
|
|
MBAC
1388
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $18.4M | 0.01% |
1,853,910
+1,428,910
| +336% | +$14M |
|
1389
PUT
PennyMac Financial
PFSI
$4.47B
| $18.3M | 0.01% |
+300,000
| New | +$19M |
|
|
SAVE
1390
DELISTED
Spirit Airlines, Inc.
SAVE
| $18.3M | 0.01% |
706,848
+330,284
| +88% | +$8.66M |
|
1391
AvalonBay Communities
AVB
$27.5B
| $18.3M | 0.01% |
82,692
-176,613
| -68% | -$39.7M |
|
1392
Genworth Financial
GNW
$3.86B
| $18.3M | 0.01% |
4,887,130
+306,491
| +7% | +$1.09M |
|
1393
iShares US Real Estate ETF
IYR
$4.75B
| $18.3M | 0.01% |
178,952
+80,023
| +81% | +$8.52M |
|
1394
iRhythm Holdings
IRTC
$4.02B
| $18.3M | 0.01% |
312,219
-238,954
| -43% | -$12.7M |
|
1395
Roku
ROKU
$21.6B
| $18.3M | 0.01% |
58,331
-292,204
| -83% | -$110M |
|
1396
nCino
NCNO
$2.06B
| $18.3M | 0.01% |
257,046
-14,747
| -5% | -$983K |
|
|
KVSA
1397
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $18.2M | 0.01% |
1,847,875
+305,614
| +20% | +$3.02M |
|
1398
Gilead Sciences
GILD
$165B
| $18.2M | 0.01% |
261,072
+159,060
| +156% | +$11.2M |
|
1399
Invesco Senior Loan ETF
BKLN
$6.96B
| $18.2M | 0.01% |
824,692
+580,478
| +238% | +$12.8M |
|
1400
Cytokinetics
CYTK
$10.6B
| $18.2M | 0.01% |
509,987
+58,105
| +13% | +$1.71M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.